Trial Profile
The effectiveness of Concerta vs. usual clinical care with immediate release methylphenidate in children (6-12 years) with attention deficit hyperactivity disorder: a randomized, open-label trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 May 2009
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Janssen Inc
- 23 Jul 2007 The expected completion date for this trial is now 1 Feb 2004.
- 14 Oct 2006 New trial record.